# Miller Industries Inc: financial statements, quarterly

MLR · NYSE · CIK 924822 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mlr.md) · [Financials](/companies/mlr/financials.md) · [Filings](/companies/mlr/filings.md) · [Insiders](/companies/mlr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mlr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [275](/filings/0001558370-24-015338.md) | [296 d](/filings/0001104659-26-023486.md) | [350](/filings/0001558370-25-006764.md) | [371](/filings/0001558370-25-010540.md) | [314](/filings/0001104659-25-107065.md) | [222 d](/filings/0001104659-26-023486.md) | [226](/filings/0001104659-26-056290.md) | [214](/filings/0001104659-26-091141.md) | [179](/filings/0001104659-25-107065.md) | [172 d](/filings/0001104659-26-023486.md) | [181](/filings/0001104659-26-056290.md) | [240](/filings/0001104659-26-091141.md) |
| Cost of revenue | $m | [232](/filings/0001558370-24-015338.md) | [258 d](/filings/0001104659-26-023486.md) | [306](/filings/0001558370-25-006764.md) | [320](/filings/0001558370-25-010540.md) | [272](/filings/0001104659-25-107065.md) | [188 d](/filings/0001104659-26-023486.md) | [192](/filings/0001104659-26-056290.md) | [179](/filings/0001104659-26-091141.md) | [153](/filings/0001104659-25-107065.md) | [145 d](/filings/0001104659-26-023486.md) | [155](/filings/0001104659-26-056290.md) | [204](/filings/0001104659-26-091141.md) |
| Gross profit | $m | [42.9](/filings/0001558370-24-015338.md) | [38.6 d](/filings/0001104659-26-023486.md) | [44.2](/filings/0001558370-25-006764.md) | [51.1](/filings/0001558370-25-010540.md) | [42.0](/filings/0001104659-25-107065.md) | [33.5 d](/filings/0001104659-26-023486.md) | [33.9](/filings/0001104659-26-056290.md) | [34.6](/filings/0001104659-26-091141.md) | [25.3](/filings/0001104659-25-107065.md) | [26.5 d](/filings/0001104659-26-023486.md) | [25.7](/filings/0001104659-26-056290.md) | [35.9](/filings/0001104659-26-091141.md) |
| Selling, general and administrative | $m | [19.3](/filings/0001558370-24-015338.md) | [16.4 d](/filings/0001104659-26-023486.md) | [21.5](/filings/0001558370-25-006764.md) | [22.8](/filings/0001558370-25-010540.md) | [22.3](/filings/0001104659-25-107065.md) | [19.7 d](/filings/0001104659-26-023486.md) | [23.3](/filings/0001104659-26-056290.md) | [23.4](/filings/0001104659-26-091141.md) | [21.2](/filings/0001104659-25-107065.md) | [21.1 d](/filings/0001104659-26-023486.md) | [23.9](/filings/0001104659-26-056290.md) | [25.2](/filings/0001104659-26-091141.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [1.8](/filings/0001558370-24-015338.md) | [1.4 d](/filings/0001104659-26-023486.md) | [1.2](/filings/0001558370-25-006764.md) | [2.0](/filings/0001558370-25-010540.md) | [0.3](/filings/0001104659-25-107065.md) | [0.4 d](/filings/0001104659-26-023486.md) | [0.1](/filings/0001104659-26-056290.md) | [0.3](/filings/0001104659-26-091141.md) | [0.1](/filings/0001104659-25-107065.md) | [0.2 d](/filings/0001104659-26-023486.md) | [0.1](/filings/0001104659-26-056290.md) | [0.4](/filings/0001104659-26-091141.md) |
| Income tax | $m | [4.6](/filings/0001558370-24-015338.md) | [4.3 d](/filings/0001104659-26-023486.md) | [4.5](/filings/0001558370-25-006764.md) | [5.7](/filings/0001558370-25-010540.md) | [4.3](/filings/0001104659-25-107065.md) | [2.1 d](/filings/0001104659-26-023486.md) | [2.7](/filings/0001104659-26-056290.md) | [2.9](/filings/0001104659-26-091141.md) | [1.2](/filings/0001104659-25-107065.md) | [1.6 d](/filings/0001104659-26-023486.md) | [1.0](/filings/0001104659-26-056290.md) | [2.8](/filings/0001104659-26-091141.md) |
| Net income | $m | [17.5](/filings/0001558370-24-015338.md) | [16.7 d](/filings/0001104659-26-023486.md) | [17.0](/filings/0001104659-25-107065.md) | [20.5](/filings/0001104659-25-107065.md) | [15.4](/filings/0001104659-25-107065.md) | [10.5 d](/filings/0001104659-26-023486.md) | [8.1](/filings/0001104659-26-091141.md) | [8.5](/filings/0001104659-26-091141.md) | [3.1](/filings/0001104659-25-107065.md) | [3.4 d](/filings/0001104659-26-023486.md) | [0.6](/filings/0001104659-26-091141.md) | [7.3](/filings/0001104659-26-091141.md) |
| Diluted EPS | $ per share | [1.52](/filings/0001558370-24-015338.md) | not reported | [1.47](/filings/0001558370-25-006764.md) | [1.78](/filings/0001558370-25-010540.md) | [1.33](/filings/0001104659-25-107065.md) | not reported | [0.69](/filings/0001104659-26-056290.md) | [0.73](/filings/0001104659-26-091141.md) | [0.27](/filings/0001104659-25-107065.md) | not reported | [0.05](/filings/0001104659-26-056290.md) | [0.63](/filings/0001104659-26-091141.md) |
| Basic EPS | $ per share | [1.53](/filings/0001558370-24-015338.md) | not reported | [1.49](/filings/0001558370-25-006764.md) | [1.79](/filings/0001558370-25-010540.md) | [1.35](/filings/0001104659-25-107065.md) | not reported | [0.70](/filings/0001104659-26-056290.md) | [0.74](/filings/0001104659-26-091141.md) | [0.27](/filings/0001104659-25-107065.md) | not reported | [0.05](/filings/0001104659-26-056290.md) | [0.64](/filings/0001104659-26-091141.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [449](/filings/0001558370-23-018257.md) | [510](/filings/0001558370-25-002276.md) | [559](/filings/0001558370-24-007367.md) | [611](/filings/0001558370-24-011387.md) | [615](/filings/0001558370-24-015338.md) | [530](/filings/0001104659-26-023486.md) | [501](/filings/0001558370-25-006764.md) | [485](/filings/0001558370-25-010540.md) | [469](/filings/0001104659-25-107065.md) | [440](/filings/0001104659-26-091141.md) | [430](/filings/0001104659-26-056290.md) | [454](/filings/0001104659-26-091141.md) |
| Total assets | $m | [587](/filings/0001558370-23-018257.md) | [647](/filings/0001558370-25-002276.md) | [697](/filings/0001558370-24-007367.md) | [748](/filings/0001558370-24-011387.md) | [755](/filings/0001558370-24-015338.md) | [667](/filings/0001104659-26-023486.md) | [640](/filings/0001558370-25-006764.md) | [623](/filings/0001558370-25-010540.md) | [604](/filings/0001104659-25-107065.md) | [590](/filings/0001104659-26-091141.md) | [586](/filings/0001104659-26-056290.md) | [609](/filings/0001104659-26-091141.md) |
| Current liabilities | $m | [189](/filings/0001558370-23-018257.md) | [235](/filings/0001558370-25-002276.md) | [275](/filings/0001558370-24-007367.md) | [294](/filings/0001558370-24-011387.md) | [291](/filings/0001558370-24-015338.md) | [198](/filings/0001104659-26-023486.md) | [155](/filings/0001558370-25-006764.md) | [146](/filings/0001558370-25-010540.md) | [136](/filings/0001104659-25-107065.md) | [137](/filings/0001104659-26-091141.md) | [145](/filings/0001104659-26-056290.md) | [185](/filings/0001104659-26-091141.md) |
| Total liabilities | $m | [255](/filings/0001558370-23-018257.md) | [299](/filings/0001558370-25-002276.md) | [334](/filings/0001558370-24-007367.md) | [368](/filings/0001558370-24-011387.md) | [360](/filings/0001558370-24-015338.md) | [266](/filings/0001104659-26-023486.md) | [233](/filings/0001558370-25-006764.md) | [204](/filings/0001558370-25-010540.md) | [184](/filings/0001104659-25-107065.md) | [169](/filings/0001104659-26-091141.md) | [168](/filings/0001104659-26-056290.md) | [189](/filings/0001104659-26-091141.md) |
| Long-term debt | $m | [60.0](/filings/0001558370-23-018257.md) | [60.0](/filings/0001558370-25-002276.md) | [55.0](/filings/0001558370-24-007367.md) | [70.0](/filings/0001558370-24-011387.md) | [65.0](/filings/0001558370-24-015338.md) | [65.0](/filings/0001104659-26-023486.md) | [75.0](/filings/0001558370-25-006764.md) | [55.0](/filings/0001558370-25-010540.md) | [45.0](/filings/0001104659-25-107065.md) | [31.1](/filings/0001104659-26-091141.md) | [21.0](/filings/0001104659-26-056290.md) | [1.0](/filings/0001104659-26-091141.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [2.2](/filings/0001104659-26-091141.md) | [2.2](/filings/0001104659-26-056290.md) | [2.1](/filings/0001104659-26-091141.md) |
| Shareholders' equity | $m | [332](/filings/0001558370-24-015338.md) | [348](/filings/0001104659-26-023486.md) | [362](/filings/0001104659-25-107065.md) | [380](/filings/0001104659-25-107065.md) | [395](/filings/0001104659-25-107065.md) | [401](/filings/0001104659-26-091141.md) | [407](/filings/0001104659-26-091141.md) | [419](/filings/0001104659-26-091141.md) | [421](/filings/0001104659-25-107065.md) | [421](/filings/0001104659-26-091141.md) | [417](/filings/0001104659-26-091141.md) | [420](/filings/0001104659-26-091141.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.3 d](/filings/0001558370-24-015338.md) | [6.8 d](/filings/0001104659-26-023486.md) | [9.0](/filings/0001558370-25-006764.md) | [(10.7) d](/filings/0001558370-25-010540.md) | [30.3 d](/filings/0001104659-25-107065.md) | [(11.7) d](/filings/0001104659-26-023486.md) | [2.7](/filings/0001104659-26-056290.md) | [27.2 d](/filings/0001104659-26-091141.md) | [19.9 d](/filings/0001104659-25-107065.md) | [48.9 d](/filings/0001104659-26-023486.md) | [30.7](/filings/0001104659-26-056290.md) | [32.2 d](/filings/0001104659-26-091141.md) |
| Capital expenditure | $m | [3.1 d](/filings/0001558370-24-015338.md) | [2.4 d](/filings/0001104659-26-023486.md) | [4.7](/filings/0001558370-25-006764.md) | [3.1 d](/filings/0001558370-25-010540.md) | [6.3 d](/filings/0001104659-25-107065.md) | [1.3 d](/filings/0001104659-26-023486.md) | [5.1](/filings/0001104659-26-056290.md) | [1.7 d](/filings/0001104659-26-091141.md) | [1.8 d](/filings/0001104659-25-107065.md) | [5.1 d](/filings/0001104659-26-023486.md) | [7.9](/filings/0001104659-26-056290.md) | [4.2 d](/filings/0001104659-26-091141.md) |
| Dividends paid | $m | [2.1 d](/filings/0001558370-24-015338.md) | [2.1 d](/filings/0001104659-26-023486.md) | [2.2](/filings/0001558370-25-006764.md) | [2.2 d](/filings/0001558370-25-010540.md) | [2.2 d](/filings/0001104659-25-107065.md) | [2.2 d](/filings/0001104659-26-023486.md) | [2.3](/filings/0001104659-26-056290.md) | [2.3 d](/filings/0001104659-26-091141.md) | [2.3 d](/filings/0001104659-25-107065.md) | [2.3 d](/filings/0001104659-26-023486.md) | [2.4](/filings/0001104659-26-056290.md) | [2.4 d](/filings/0001104659-26-091141.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.9 d](/filings/0001104659-25-107065.md) | [0.0 d](/filings/0001104659-26-023486.md) | [2.1](/filings/0001104659-26-056290.md) | [0.5 d](/filings/0001104659-26-091141.md) | [1.2 d](/filings/0001104659-25-107065.md) | [2.2 d](/filings/0001104659-26-023486.md) | [2.2](/filings/0001104659-26-056290.md) | [2.5 d](/filings/0001104659-26-091141.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.4](/filings/0001558370-23-018257.md) | [11.4](/filings/0001558370-24-007367.md) | [11.5](/filings/0001558370-24-011387.md) | [11.5](/filings/0001558370-24-015338.md) | [11.6](/filings/0001558370-25-006764.md) | [11.5](/filings/0001558370-25-010540.md) | [11.6](/filings/0001104659-25-107065.md) | [11.6](/filings/0001104659-26-056290.md) | [11.6](/filings/0001104659-26-091141.md) | [11.6](/filings/0001104659-25-107065.md) | [11.5](/filings/0001104659-26-056290.md) | [11.5](/filings/0001104659-26-091141.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,352,184 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001104659-26-091141.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.